Bullish divergence on the MACD and ADX. Price near last low. Low risk play with high potential in the short term.
Pupm&Dump trading strategy idea. $ADAP is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $6,29; stop-loss — $6,52; take-profit — $5,82/MOC Do not view this idea as a recommendation for trading or investing. It is...
Dragon pattern. Weekly classic bullish divergence on the MACD. Stop = Close below resistance 1st Target = Resistance/0.236 fib extension 2nd Target = Resistance/0.5 fib extension
I am long ADAP at $4.01 Breakdown on the psychology behind the move.
BUY ADAP - ADAPTIMMUNE THERAPEUTICS - STRONG BUY ON WEEKLY CHART
This stock has shown breakout earlier creating wave 1 then it created its wave 3 when it had its stronger breakout now its doing a flat sideways tight range wave 4 The NEXT breakout will be a wave 5 up
Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications -------------------------------------------------------------- Partial Responses seen in liver, melanoma, gastro-esophageal junction, and head and neck cancers. -------------------------------------------------------------- Encouraging demonstration of the...
In the Surpass trial, three of the first four patients treated with ADP-A2M4CD8 had smaller tumors at the last checkup than they did at the outset. ---------------------------------------------------------- Eight out of 16 patients with synovial sarcoma have shown partial responses to treatment with ADP-A2M4....
This over reaction to news and an approval may result in another handle on this left-facing cup and handle. Best of luck. -zm
Contextual immersion trading strategy idea. Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States. Friday morning the company presented positive data on its experimental cell therapy, which is designed to treat a range of cancers. It causes...
There's absolutely no reason this security should have exploded higher like this. Would not be the least bit surprised to see a pullback to $7-8 after a big pump like this. One way you could play it is with low cost $5 strike puts.
More speculative as is a bio pharmaceutical. One bad news release can lead to big drop. Chart looks good to me. Notice the positive reversal in the daily RSI. Could use close below the current up trend line as a stop.Yellow box is near term target but if price blasts though that level it would be very bullish. Process your way. Take care.
Double Bottom at 3.60...long term support. Breaking through the wedge now. Clinical trial results in May.
As the company ADAP has not been performing as desired within the last few years, an analysis may manifest that the trajectory for the stock valuation has almost amassed an all-time low valuation. Not investment advice. For personal and educational purposes only. (Move with caution and due diligence)
see chart for details.
Strong Fundamental data has created the more recent bullish trend. I have been waiting for a safe entry point for about 2 months now after selling off some profits in the 13s. mid 10s has been my forecast for optimum entry for some time now and it looks like we are just about there. I am thinking that I will phase in throughout this week and set a stop around...